A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)

Phase 4

Completed

• Conditions: Acute Gout

• Registration Number: NCT00142558
• Lead Sponsor: Organon and Co

Brief Summary

A study to evaluate the effects of etoricoxib and indomethacin in the treatment of acute gout.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-01-01
• Primary Completion: 2005-05-01
• Study Completion: 2005-05-01
• Study First Submitted: 2005-08-31
• Study First Submitted QC: 2005-08-31
• Study First Posted: 2005-09-02
• Status Verified: 2022-02
• Last Update Submitted: 2024-08-12
• Last Update Posted: 2024-08-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

• Males or females at least 18 years of age who have acute gout.

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Patient assessment of pain (0- to 4- Likert scale)

Secondary Outcome Measures

Name	Time	Method
Patient Global Assessment of Response to Therapy (0- to 4- point scale)
Investigator Global Assessment of Response to Therapy (0- to 4- point scale)
Tenderness of the study joint (0- to 3-point scale)
Swelling of the study joint (0- to 3-point scale)